August 10, 2020
GAITHERSBURG, Md., Aug. 09, 2020 (GLOBE NEWSWIRE) — As disclosed in OpGen, Inc.’s (NASDAQ: OPGN) (“OpGen” or “the Company”) July 13, 2020 press release, we have […]
July 27, 2020
BBC.Com 19-July-2020. While the latest research suggests that antibodies against Covid-19 could be lost in just three months, a new hope has appeared on the horizon: […]
July 27, 2020
The U.S. Food and Drug Administration on 19 July approved testing pooled batches of samples for the COVID-19 virus, a strategy supporters say could help screen […]
July 15, 2020
BOLOGNA, Italy and HUNTINGDON VALLEY, Pa. and GAITHERSBURG, Md., July 13, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN), a precision medicine company harnessing the power […]
July 15, 2020
Jul 15, 2020 By Mark Terry (BioSpace) – In mid-May, Moderna released positive interim data from its Phase I trial of mRNA-1273, its mRNA vaccine against […]
July 8, 2020
By Robert Bazell – Science 26 Jun 2020: Vol. 368, Issue 6498, pp. 1413. Michael Mina is out for blood—millions of samples, which a nascent effort […]
June 19, 2020
19-JUN-2020 (https://www.infectiousdiseaseadvisor.com/) The Unyvero HPN panel provides comprehensive diagnostic information to clinicians in less than 5 hours, with only minutes of actual hands-on time. The Unyvero […]
June 4, 2020
GenomeWeb – NEW YORK – OpGen announced Wednesday the expansion of its strategic collaboration with the New York State Department of Health after the firm hit […]
June 1, 2020
BIRMINGHAM, Ala. and STUTTGART, Germany, May 26, 2020 /PRNewswire/ — BioGX and Bosch Healthcare Solutions have partnered to develop point-of-care infectious disease tests for the Bosch […]
